iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 4,380.00
+5.00 (0.11%)
Jul 18, 2025, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 138.47 billion as of July 18, 2025. Its market cap has decreased by -32.82% in one year.
Market Cap
138.47B
Enterprise Value
93.73B
Revenue
5.69B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,380.00
Market Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 138.47B, an increase of 45.30%. That is a compound annual growth rate of 2.61%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.80T |
| Celltrion | 39.82T |
| ALTEOGEN | 26.19T |
| Yuhan | 9,866.54B |
| SK Biopharmaceuticals | 8,066.26B |
| HLB Co., Ltd. | 6,939.04B |
| Peptron | 6,861.07B |
| PharmaResearch | 5,890.93B |